GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 30 filers reported holding GEMPHIRE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Exchange Capital Management, Inc. | 532,381 | $5,425,000 | 1.61% |
| NORTHPOINTE CAPITAL LLC | 698,802 | $7,121,000 | 0.94% |
| Cormorant Asset Management, LP | 1,041,635 | $10,614,000 | 0.78% |
| Stonepine Capital Management, LLC | 103,000 | $1,050,000 | 0.64% |
| Wilks Brothers, LLC | 158,547 | $1,616,000 | 0.17% |
| GM Advisory Group, LLC | 43,335 | $442,000 | 0.13% |
| Telemetry Investments, L.L.C. | 15,488 | $158,000 | 0.06% |
| JBF Capital, Inc. | 20,000 | $204,000 | 0.03% |
| BAMCO INC /NY/ | 469,860 | $4,788,000 | 0.02% |
| Cambridge Investment Research Advisors, Inc. | 167,364 | $1,705,000 | 0.02% |